2022 Revenues ($USD) : $778,639,000 2022 R&D spend : $297,800,000 2022 Number of Employees : 8019 Fiscal Year End : 12/31/2021 Company CEO : Zhaohua Chang, chair
Founded in Shanghai in 1998, MicroPort develops and manufactures products for a range of medical fields, including cardiology, interventional radiology, orthopedics, electrophysiology and surgical management. The company focuses on minimally invasive medical devices for the treatment of cardiac arrhythmia disease. It has developed a family of cardiac ablation catheters, diagnostic catheters, and 3D navigation systems used by hundreds of physicians at over 600 hospitals across China and elsewhere. –SW